<DOC>
	<DOCNO>NCT00237900</DOCNO>
	<brief_summary>To assess safety , efficacy explorative objective gefitinib combination chemoradiation resectable gastric cancer</brief_summary>
	<brief_title>Gefitinib Combination With Chemoradiation Resectable Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>Histologicallyconfirmed intestinal GC ( T2T4 ) Local locally advance stage II stage III gastric cancer upper part stomach GE junction Lymph node positive negative Metastasis negative Resection curative intent ( R0 , D2 ) Chemo radiotherapy na√Øve Measurable lesion accord RECIST Written inform consent Aged 45 70 Prior gastric surgery Active ILD</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>